Is cefalexin (Keflex) taken three times daily appropriate for a patient with recurrent urinary tract infection?

Cephalexin TID is NOT the standard dosing for recurrent UTI prophylaxis or treatment

For recurrent UTI prophylaxis, cephalexin 250 mg once daily is the appropriate dose when antibiotics are used, not TID dosing. For acute UTI treatment episodes, cephalexin 500 mg BID is equally effective and more practical than TID or QID dosing 1, 2.

Context: Prophylaxis vs. Acute Treatment

The question about "recurrent UTI" requires clarification of whether you're treating an acute episode in someone with a history of recurrent UTIs, or providing prophylaxis to prevent future episodes:

For Prophylaxis (Prevention of Future UTIs)

• Cephalexin 250 mg once daily is the guideline-recommended dose for antibiotic prophylaxis 3
• This is NOT a TID regimen
• Consider non-antibiotic options first (cranberry with ≥36 mg PACs, methenamine hippurate 1g BID, increased water intake if baseline <1.5L/day) 3, 4
• Reserve antibiotic prophylaxis for patients who fail non-antibiotic measures

For Acute Treatment Episodes

Cephalexin 500 mg BID for 7-14 days is appropriate and equivalent to QID dosing 5, 1, 2:

• The FDA label states 500 mg every 12 hours is acceptable for uncomplicated cystitis 5
• Recent high-quality evidence shows no difference in treatment failure between BID (12.7%) vs QID (17%) dosing (P=0.343) 2
• Another 2025 study of 214 patients found no significant difference: BID 18.7% vs QID 15.0% failure rates (P=0.465) 1
• BID dosing improves adherence without compromising efficacy

Why TID Dosing is Problematic

• TID is not a standard dosing interval for cephalexin in any guideline or FDA labeling 5
• Standard options are QID (every 6 hours), BID (every 12 hours), or once daily for prophylaxis
• TID creates awkward dosing times and reduces adherence
• No evidence supports TID as superior to BID for efficacy

Guideline-Based Approach for Recurrent UTI

First-line alternatives to cephalosporins per 2024 EAU guidelines 4:

• Fosfomycin 3g single dose
• Nitrofurantoin 100 mg BID for 5 days
• Pivmecillinam 400 mg TID for 3-5 days

Cephalosporins (including cephalexin) are listed as alternatives, appropriate when local E. coli resistance is <20% 4

Critical Caveats

• Confirm susceptibility: Cephalexin only works for non-ESBL-producing Enterobacteriaceae 6
• Use cefazolin susceptibility as surrogate for cephalexin per CLSI/USCAST guidelines 6
• Duration matters: 7-14 days for cystitis treatment 5, not the 3-day courses used for some first-line agents
• For men with UTI, consider 7-day courses as infections are inherently more complicated 4

Bottom Line Algorithm

1. For prophylaxis: Use cephalexin 250 mg once daily (not TID), or preferably try non-antibiotic options first
2. For acute treatment: Use cephalexin 500 mg BID for 7-14 days (not TID)
3. Never use TID dosing - it lacks evidence and creates adherence problems
4. Consider whether cephalexin is appropriate at all given guideline preference for fosfomycin, nitrofurantoin, or pivmecillinam as first-line agents